Enovis Retained Earnings (Accumulated Deficit) 2010-2025 | ENOV
Enovis retained earnings (accumulated deficit) from 2010 to 2025. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
| Enovis Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024 | $-283 |
| 2023 | $542 |
| 2022 | $576 |
| 2021 | $589 |
| 2020 | $517 |
| 2019 | $480 |
| 2018 | $992 |
| 2017 | $846 |
| 2016 | $685 |
| 2015 | $557 |
| 2014 | $390 |
| 2013 | $19 |
| 2012 | $-139 |
| 2011 | $-56 |
| 2010 | $-60 |
| 2009 | $-76 |
| Enovis Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2025-03-31 | $-339 |
| 2024-12-31 | $-283 |
| 2024-09-30 | $420 |
| 2024-06-30 | $452 |
| 2024-03-31 | $470 |
| 2023-12-31 | $542 |
| 2023-09-30 | $540 |
| 2023-06-30 | $542 |
| 2023-03-31 | $552 |
| 2022-12-31 | $576 |
| 2022-09-30 | $614 |
| 2022-06-30 | $681 |
| 2022-03-31 | $604 |
| 2021-12-31 | $589 |
| 2021-09-30 | $591 |
| 2021-06-30 | $565 |
| 2021-03-31 | $536 |
| 2020-12-31 | $517 |
| 2020-09-30 | $484 |
| 2020-06-30 | $471 |
| 2020-03-31 | $479 |
| 2019-12-31 | $480 |
| 2019-09-30 | $496 |
| 2019-06-30 | $486 |
| 2019-03-31 | $955 |
| 2018-12-31 | $992 |
| 2018-09-30 | $946 |
| 2018-06-30 | $915 |
| 2018-03-31 | $876 |
| 2017-12-31 | $846 |
| 2017-09-30 | $833 |
| 2017-06-30 | $787 |
| 2017-03-31 | $734 |
| 2016-12-31 | $685 |
| 2016-09-30 | $648 |
| 2016-06-30 | $620 |
| 2016-03-31 | $580 |
| 2015-12-31 | $557 |
| 2015-09-30 | $513 |
| 2015-06-30 | $495 |
| 2015-03-31 | $442 |
| 2014-12-31 | $390 |
| 2014-09-30 | $309 |
| 2014-06-30 | $236 |
| 2014-03-31 | $44 |
| 2013-12-31 | $19 |
| 2013-09-30 | $-13 |
| 2013-06-30 | $-63 |
| 2013-03-31 | $-116 |
| 2012-12-31 | $-139 |
| 2012-09-30 | $-154 |
| 2012-06-30 | $-158 |
| 2012-03-31 | $-165 |
| 2011-12-31 | $-56 |
| 2011-09-30 | $-39 |
| 2011-06-30 | $-43 |
| 2011-03-31 | $-54 |
| 2010-12-31 | $-60 |
| 2010-09-30 | $-69 |
| 2010-06-30 | $-90 |
| 2010-03-31 | $-92 |
| 2009-12-31 | $-76 |
| 2009-09-30 | $-97 |
| 2009-06-30 | $-102 |
| 2009-03-31 | $-106 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.765B | $2.108B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.644B | 58.07 |
| Doximity (DOCS) | United States | $11.655B | 53.96 |
| Hims & Hers Health (HIMS) | United States | $11.295B | 117.35 |
| Tempus AI (TEM) | United States | $9.675B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.275B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.775B | 58.99 |
| Hinge Health (HNGE) | United States | $3.572B | 0.00 |
| Privia Health (PRVA) | United States | $2.516B | 172.00 |
| Phreesia (PHR) | United States | $1.591B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.517B | 0.00 |
| 10x Genomics (TXG) | United States | $1.505B | 0.00 |
| Schrodinger (SDGR) | United States | $1.495B | 0.00 |
| Azenta (AZTA) | United States | $1.461B | 67.89 |
| Evolent Health (EVH) | United States | $1.335B | 113.70 |
| Omnicell (OMCL) | United States | $1.276B | 22.51 |
| Claritev (CTEV) | United States | $0.717B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.550B | 0.00 |
| Veradigm (MDRX) | United States | $0.536B | 0.00 |
| Standard BioTools (LAB) | United States | $0.463B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.435B | 0.00 |
| Talkspace (TALK) | United States | $0.420B | 125.50 |
| TruBridge (TBRG) | United States | $0.321B | 713.00 |
| Outset Medical (OM) | United States | $0.320B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.270B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.260B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.231B | 0.00 |
| CapsoVision (CV) | United States | $0.213B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.203B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.136B | 0.00 |
| American Well (AMWL) | United States | $0.125B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.120B | 0.00 |
| Pulmonx (LUNG) | United States | $0.109B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.103B | 0.00 |
| CareCloud (CCLD) | United States | $0.098B | 3.73 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.083B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.080B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.046B | 0.00 |
| HeartBeam (BEAT) | United States | $0.042B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |